US 8796436
Modified iRNA agents
granted A61KA61K47/55A61K47/554
Quick answer
US patent 8796436 (Modified iRNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K47/55, A61K47/554